Weill Cornell Medicine Urology
Weill Cornell Medicine Urology
Urogenital Atrophy

Urogenital Atrophy

Find a Physician


Quickly search our world-class physicians and faculty by keyword, location and insurance provider.


Bilal Chughtai

Bilal Chughtai, MD is an Associate Professor of Urology and an Associate Professor of Urology in Obstetrics and Gynecology at Weill Cornell Medicine. He is also an Associate Attending Urologist at NewYork-Presbyterian Hospital. Dr. Chughtai specializes in Voiding Dysfunction, Female Urology, and Neurourology.

Urogenital Atrophy - Treatment Options

The most effective treatment for urogenital atrophy is low-dose vaginal estrogen replacement. This topical estrogen comes in a variety of preparations including a cream, suppository, and intravaginal ring. It is important to be aware that low-dose vaginal estrogen replacement is NOT the same as systemic estrogen replacement therapy used to treat hot flashes and bone loss.

Urogenital Atrophy - Risks & Causes

Urogenital atrophy typically occurs due to declining estrogen levels in menopause. However, decreased estrogen stimulation of urogenital tissue can also occur in premenopausal women.

Urogenital Atrophy - Symptoms & Evaluation

Symptoms of urogenital atrophy include vaginal dryness, itching or irritation, pain with intercourse, recurrent urinary tract infections, urinary frequency and urgency, pale and thin vaginal skin, narrowing or shortening of the vagina, and other anatomical changes.

Brady Urologic Health Center

The Brady Urologic Health Center is located within an 8,000 square foot suite on the ninth floor of the Starr Pavilion at Weill Cornell Medicine/New York-Presbyterian Hospital and is composed of a close-knit team of physicians, working together to provide treatment for the broad spectrum of urologic conditions.

Find a Physician FIND A PHYSICIAN

© 2016 Weill Cornell Medicine All rights reserved.